Patent Assignment
Reel/Frame 062471/0259
Merger
Recorded: 2023-01-24
Pages: 4
Assignor
VIGENE BIOSCIENCES INC.
Executed: 2021-12-21
Assignee
CHARLES RIVER LABORATORIES, INC.
251 BALLARDVALE STREET, WILMINGTON, MASSACHUSETTS, 01887
Covered Property
(1)
Non-Integrating Hiv-1 Comprising Mutant Rt/in Proteins and Pseudotyped with Sars-Cov-2 Spike Protein
Patent:
11,129,890 →
Application:
16/877,839 →
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
Sep 8, 2020
From: VIGENE BIOSCIENCES, INC.
To: BROADOAK FUND IV, LLC
Reel/Frame 053713/0741 →
Assignment of Assignor's Interest
Dec 30, 2020
From: SUN, ZAIREN
To: VIGENE BIOSCIENCES, INC.
Reel/Frame 054774/0395 →
Release of Security Interest
Jun 29, 2021
From: BROADOAK FUND IV, LLC
To: VIGENE BIOSCIENCES, INC.
Reel/Frame 056703/0730 →
Security Interest
Dec 13, 2024
From: CHARLES RIVER LABORATORIES, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 069647/0925 →